Overactive Bladder
The Effect of Social Determinants of Health on Overactive Bladder Symptom Severity.
December 27, 2020
[Follow-up and evaluation of non-neurogenic OAB treatments].
December 27, 2020
The impact of overactive bladder on health-related quality of life in Korea: based on the results of a Korean Community Health Survey.
December 27, 2020
Do Older Adults with Overactive Bladder Demonstrate Impaired Executive Function Compared to Their Peers Without OAB?
December 20, 2020
Vibegron Improves Quality-of-Life Measures in Patients With Overactive Bladder: Patient-Reported Outcomes From the EMPOWUR Study.
December 20, 2020
Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity.
December 6, 2020
Mirabegron Add-On Therapy to Tamsulosin in Men with Overactive Bladder: Post Hoc Analyses of Efficacy from the MATCH Study.
November 29, 2020
[First-line treatment for non-neurogenic overactive bladder].
November 29, 2020
Shifting the treatment paradigm in idiopathic overactive bladder.
November 22, 2020
Prevalence and bother of lower urinary tract symptoms and overactive bladder in Poland, an Eastern European Study.
November 22, 2020
Urovant Sciences Announces Positive Clinical Efficacy and Safety Data from Vibegron EMPOWUR Long Term Extension Study
November 19, 2020
A comparative study between sacral neuromodulation and intravesical botulinum toxin injection for patients with refractory overactive bladder.
November 15, 2020